JP2024517788A5 - - Google Patents
Info
- Publication number
- JP2024517788A5 JP2024517788A5 JP2023567063A JP2023567063A JP2024517788A5 JP 2024517788 A5 JP2024517788 A5 JP 2024517788A5 JP 2023567063 A JP2023567063 A JP 2023567063A JP 2023567063 A JP2023567063 A JP 2023567063A JP 2024517788 A5 JP2024517788 A5 JP 2024517788A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- inhibitor
- amino
- cdk4
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184422P | 2021-05-05 | 2021-05-05 | |
| US63/184,422 | 2021-05-05 | ||
| PCT/IB2022/053970 WO2022234409A1 (en) | 2021-05-05 | 2022-04-28 | Compounds and compositions for the treatment of mpnst |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517788A JP2024517788A (ja) | 2024-04-23 |
| JP2024517788A5 true JP2024517788A5 (https=) | 2025-05-07 |
Family
ID=81598046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567063A Pending JP2024517788A (ja) | 2021-05-05 | 2022-04-28 | Ｍｐｎｓｔの処置のための化合物及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240238284A1 (https=) |
| EP (1) | EP4333847A1 (https=) |
| JP (1) | JP2024517788A (https=) |
| CN (1) | CN117177752A (https=) |
| TW (1) | TW202308631A (https=) |
| WO (1) | WO2022234409A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025510572A (ja) | 2022-03-08 | 2025-04-15 | レボリューション メディシンズ インコーポレイテッド | 免疫不応性肺癌を治療するための方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1761528T1 (sl) | 2004-06-11 | 2008-06-30 | Japan Tobacco Inc | 5-amino-2,4,7-triokso-3,4,7,8-tetrahidro-2H-pirido(2,3-D)pirimidinski derivati in sorodne spojine za zdravljenje raka |
| ES2522346T3 (es) | 2008-08-22 | 2014-11-14 | Novartis Ag | Compuestos de pirrolopirimidina como inhibidores de CDK |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| EP4302834A3 (en) | 2016-07-12 | 2024-07-17 | Revolution Medicines, Inc. | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
| EP3923941B1 (en) * | 2019-02-12 | 2025-12-03 | Novartis AG | Pharmaceutical combination comprising tno155 and ribociclib |
-
2022
- 2022-04-28 CN CN202280029051.XA patent/CN117177752A/zh active Pending
- 2022-04-28 WO PCT/IB2022/053970 patent/WO2022234409A1/en not_active Ceased
- 2022-04-28 US US18/558,756 patent/US20240238284A1/en active Pending
- 2022-04-28 EP EP22722574.5A patent/EP4333847A1/en active Pending
- 2022-04-28 JP JP2023567063A patent/JP2024517788A/ja active Pending
- 2022-04-29 TW TW111116420A patent/TW202308631A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519375A5 (https=) | ||
| JP2024526145A5 (https=) | ||
| JP6141958B2 (ja) | 増殖性疾患の治療のための併用療法（ベムラフェニブ及びｍｄｍ２阻害剤） | |
| JP2022519385A5 (https=) | ||
| JP2022517433A5 (https=) | ||
| JP2019516733A5 (https=) | ||
| JP2021534094A5 (https=) | ||
| JP2016523858A (ja) | がんを治療するためのｂｔｋ阻害剤とフルオロウラシルとの併用 | |
| JP2015517523A5 (https=) | ||
| MX2024006271A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| CN104039148A (zh) | 组合als疗法 | |
| JP2023524789A5 (https=) | ||
| Punt | New drugs in the treatment of colorectal carcinoma | |
| JP2024517788A5 (https=) | ||
| TW201625243A (zh) | 用於治療黑素瘤之藥物組合 | |
| JP2016505050A5 (https=) | ||
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| Kaushik et al. | Apremilast in orofacial granulomatosis—A report of five cases. | |
| JP2021503448A5 (https=) | ||
| TW200306185A (en) | Combinations comprising EPOTHILONES and anti-metabolites | |
| JPWO2021206167A5 (https=) | ||
| JP2022504435A5 (https=) | ||
| JP2021512140A5 (https=) | ||
| JP2024518426A5 (https=) | ||
| TW202327579A (zh) | Ｔｅａｄ抑制劑的給藥方案 |